Study: Nodular Basal Cell Carcinoma (BCC)

The Dermatology Institute of Victoria in collaboration with Feldan Therapeutics are currently seeking participants that have been diagnosed with or have suspected Nodular Basal Cell Carcinoma (nBCC), for participation in a clinical trial of a potential new investigational intralesional treatment called FLD-103.

Eligibility criteria:

• Males & Females aged 18 to 85 years old.

• Diagnosed or suspected nBCC that has not been removed or previously treated.

• Diagnosis has been confirmed via a punch biopsy. 

• No melanoma within the past five (5) years. 

• The nBCC lesion is not in high-risk anatomic location (e.g. ocular/peri-ocular, nose/perinasal, ears, lips/perioral, scalp, fingers/hands). 

Eligible participants will receive study-related treatment at no charge and will be reimbursed for time and travel. 

For details, please contact Daniela Borzillo Tel: (03) 9826 4966 or Email: clinicaltrials@div.net.au

Interested in learning more?

Fill in your details below and we’ll contact you with further information.